Tag: Wen Zexiong
Firms act on Kelun-Biotech’s HKD1.9bn H-share placement
Zhong Lun, S&C, Kirkland & Ellis advised on Kelun-Biotech’s HKEX H-share placement raising HKD1.94b (USD250m)
Five law firms advise on Kelun-Biotech’s USD174m HK debut
Five law firms counselled parties involved in the HKD1.36 billion (USD174 million) listing of innovative biomedicine company Kelun-Biotech Pharmaceutical in Hong Kong



















